Clinical and biochemical parameters related to cardiovascular disease after Helicobacter pylori eradication

International Angiology

Volumn 28, Issue 6, 2009, Pages 469-473

  Pellicano, R ^a   Oliaro, E ^b   Fagoonee, S ^b   Astegiano, M ^a   Berrutti, M ^c   Saracco, G ^a   Smedile, A ^a   Repici, A ^d   Leone, N ^c   Castelli, A ^e   Luigiano, C ^f   Fadda, M ^a   Rizzetto, M ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c GRADENIGO HOSPITAL   (Italy)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e Villa Adriana Clinic   (Italy)

^f BELLARIA HOSPITAL   (Italy)

Author keywords

Cardiovascular diseases; Coronary disease; Helicobacter pylori; Myocardial infarction; Myocardial ischemia

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER;

ADULT; ARTICLE; BIOCHEMISTRY; BLOOD EXAMINATION; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DUODENUM ULCER; DYSPEPSIA; ERADICATION THERAPY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; GLUCOSE BLOOD LEVEL; HELICOBACTER INFECTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; STOMACH ULCER; STUDENT T TEST; TRIACYLGLYCEROL BLOOD LEVEL; UREA BREATH TEST; BLOOD; BLOOD PRESSURE; BREATH ANALYSIS; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPLICATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; ITALY; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOGENICITY; PATHOPHYSIOLOGY; REMISSION; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; BREATH TESTS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; FEMALE; FIBRINOGEN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ITALY; MALE; MIDDLE AGED; REMISSION INDUCTION; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77950613118     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Mehta PK, Wenger NK. Coronary heart disease in women: battle is won, but the war remains. Minerva Med 2007;98:459-78.
2. Schafer R, Northoff H. Cardioprotection and cardiac regeneration by mesenchymal stem cells. Panminerva Med 2008;50:31-9.
3. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000;356:279-84.
4. Fardi A, Papadimitriou D. Periodontal and atherosclerosis-induced diseases. Int Angiol 2007;26:197-205.
5. Libby P, Egan D, Skarlatos S. Role of infectious agents in atherosclerosis and restenosis. Circulation 1997;96:4095-103.
6. Biyik I, Canbaz MA, Ergene O. Seasonal variability of acute myocardial infarction in a Western Anatolian city and its relations to acute infections and climate. Int Angiol 2007;26:285-9.
7. Oliaro E, Fagoonee S, Pellicano R. On acute respiratory tract infections and acute myocardial infarction. New data confirm previous findings. Int Angiol 2007;26:391-2.
8. Guiglia R, Lo Russo L, Coccia E, Di Liberto C, D'Angelo M, Indovina G et al. The association between periodontal diseases and cardiovascular diseases: a narrative review. Panminerva Med 2008;50:327-37.
9. Pellicano R, Fagoonee S, Rizzetto M. On infections and ischemic heart diseases. Int Angiol 2007;26:390-1.
10. Ridker PM, Cushman M, Stamper MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
11. Novo G, Corrado E, Muratori I, Tantillo R, Bellia A, Galluzzo A et al. Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome. Int Angiol 2007;26:312-7.
12. Dore MP, Graham DY. Gastritis, dyspepsia and peptic ulcer disease. Minerva Med 2008;99:323-33.
13. Moyaert H, Franceschi F, Roccarina D, Ducatelle R, Haesebrouck F, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection: other Helicobacters. Helicobacter 2008;13(S1):47-57.
14. Pellicano R, Ménard A, Rizzetto M, Mégraud F. Helicobacter species and liver diseases: association or causation? Lancet Infect Dis 2008;8:254-60.
15. Berrutti M, Pellicano R, Fagoonee S, Astegiano M, Smedile A, Saracco G et al. Potential relationship between Helicobacter pylori and ischemic heart disease:any pathogenic model? Panminerva Med 2008;50:161-3.
16. Ando T, Minami M, Ishiguro K, Maeda O, Watanabe O, Mizuno T et al. Changes in biochemical parameters related to atherosclerosis after Helicobacter pylori eradication. Aliment Pharmacol Ther 2006;24:58-64.
17. Niemelä S, Karttunen T, Korhonen T, Läärä E, Karttunen R, Ikäheimo M et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 1996;75:573-5.
18. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-anlyses. BMJ 2000;321:199-204.
19. Schweeger I, Fitscha P, Sinzinger H. Successful eradication of Helicobacter pylori as determined by 13C-urea breath test does not alter fibrinogen and acute phase response markers. Thromb Res 2000;97:411-20.
20. Patel P, Carrington D, Strachan DP, Leatham E, Goggin P, Northfield Tc et al. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet 1994;343:1634-5.
21. Pellicano R, Bonardi R, Smedile A, Saracco G, Ponzetto A, Lagget M et al. Gastroenterology outpatient clinic of the Molinette Hospital (Turin, Italy): the 2003-2006 report. Minerva Med 2007;98:19-23.
22. Lowe AM, Yansouni CP, Behr MA. Causality and gastrointestinal infections: Koch, Hill, and Crohn's. Lancet Infect Dis 2008;8:720-6.
23. Braunwald E. Shattuck letture- Cardiovascular medicine at the turn of the millenium: triumphs, concerns and opportunities. N Engl J Med 1997;337:1360-9.
24. De Luis DA, Garcia Avello A, Lasuncion MA, Aller R, Martin de Argila C, Boixeda de Miquel D et al. Improvement in lipid and hemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients. Clin Nutr 1999;18:227-31.
25. Elizalde JI, Pérez-Pujol S, Heras M, Sionis A, Casanovas N, Martorell T et al. Effects of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes. Helicobacter 2004;9:681-9.
26. Elizalde JI, Piqué JM, Moreno V, Morillas JD, Elizalde I, Bujanda L et al. Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen. Aliment Pharmacol Ther 2002;16:577-86.
27. Koenig W, Hoffmeister A, Hombach V. Hyperfibrinogenemia and cardiovascular risk:possible strategies for intervention. Fibrinol Proteol 1997;11:41-6.
28. Torgano G, Cosentini R, Mandelli C, Perondi R, Blasi F, Bertinieri G et al. Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. Circulation 1999;99:1555-9.
29. Yusuf SW, Mishra RM. Effect of Helicobacter pylori infection on fibrinogen level in elderly patients with ischaemic heart disease. Acta Cardiol 2002;57:317-22.
30. Franceschi F, Leo D, Fini L, Santoliquido A, Flore R, Tondi P et al. Helicobacter pylori infection and ischaemic heart disease: an overview of the general literature. Dig Liver Dis 2005;37:301-8.
31. Liu L, Liu Y, Tong W, Ye H, Zhang X, Cao W et al. Pathogen burden in essential hypertension. Circ J 2007;71:1761-4.
32. Di Bonaventura G, Piccolomini R, Pompilio A, Zappacosta R, Piccolomini M, Neri M. Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is there a relationship? Int J Immunopathol Pharmacol 2007;20:163-72.
33. Thjodleifsson B, Olafsson I, Gislason D, Gislason T, Jögi R, Janson C. Infections and obesity: A multinational epidemiological study. Scand J Infect Dis 2008;40:381-6.
34. Chuang C-H, Sheu B-S, Yang H-B, Lee S-C, Kao A-W, Cheng H-C et al. Gender difference of circulating ghrelin and leptin concentrations in chronic Helicobacter pylori infection. Helicobacter 2009;14:54-60.